Back
Xencor 10K Form
Buy
65
XNCR
Xencor
Last Price:
25.26
Seasonality Move:
4.37%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-09 | 10Q | XNCR/Xencor Quarterly |
| 2023-11-08 | 10Q | XNCR/Xencor Quarterly |
| 2023-08-03 | 10Q | XNCR/Xencor Quarterly |
| 2023-05-08 | 10Q | XNCR/Xencor Quarterly |
| 2022-11-07 | 10Q | XNCR/Xencor Quarterly |
| 2022-08-03 | 10Q | XNCR/Xencor Quarterly |
Receive XNCR News And Ratings
See the #1 stock for the next 7 days that we like better than XNCR
XNCR Financial Statistics
Sales & Book Value
| Annual Sales: | $168.34M |
|---|---|
| Cash Flow: | $-28.14M |
| Price / Cash Flow: | 60.12 |
| Annual Sales: | $10.35 |
| Price / Book: | 2.45 |
Profitability
| EPS (TTM): | -3.20000 |
|---|---|
| Net Income (TTM): | $-198.24M |
| Gross Margin: | $0 |
| Return on Equity: | -30.65% |
| Return on Assets: | -22.4% |
Xencor Earnings Forecast
Key Xencor Financial Ratios
- The Gross Profit Margin over the past 4 years for XNCR is 0.00%.
- The Selling, General & Administrative Expenses for XNCR have been equal to 31.71% of Gross Profit Margin.
- The Research & Development expenses have been 150.65% of Revenue.
- The Interest Expense is -0.03% of Operating Income.
- The Net Earning history of XNCR is -74.90% of Total Revenues.
- Per Share Earnings over the last 13 years have been positive in 6 years.
Xencor Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | XNCR |
| CUSIP: | 98401F |
| Website: | xencor.com |
Debt
| Debt-to-Equity Ratio: | 0.02 |
|---|---|
| Current Ratio: | 6.23 |
| Quick Ratio: | 6.01 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |